Health

Novavax Announces Proposed Offering of $125 Million of Convertible Senior Notes

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced a proposed offering of $125 million aggregate principal amount of convertible senior notes due 2027 (the “notes”). The notes will be offered and sold only to persons reasonably believed to be qualified institutional buyers pursuant […]

thaipr.net

16 ธ.ค. 65

Youth at Risk of Being Left Behind in Asia Pacific Tuberculosis Response, Regional Forum Spotlights

Johnson & Johnson, together with the Global Fund and Asian Venture Philanthropy Network, convene 2nd annual Asia Pacific Tuberculosis Forum to advance progress toward ending tuberculosis in the region Youth are at risk of being missed from diagnosis if not engaged and empowered in fight against TB among key focus at Forum Over the course of two […]

thaipr.net

13 ธ.ค. 65

Pharming announces publication of data from Phase 3 Study of leniolisib in patients with APDS in ASH’s Blood

Leniolisib was well tolerated and significant improvement over placebo was notable in the co-primary endpoints, reflecting a favorable impact on patients’ immune dysregulation and deficiency The peer-reviewed publication heightens international understanding of APDS, a rare and recently characterized immunodeficiency Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM) (Nasdaq: PHAR)…

thaipr.net

8 ธ.ค. 65

Apollo Proton Cancer Centre successfully performs Asia’s 1st Brain Bypass Surgery on twin children with Moya Moya Disease

Apollo Proton Cancer Centre (APCC) recently performed Asia’s first brain bypass surgery on twin 8-year-old children from the Netherlands. The integration of advanced technology and expertise at APCC helped the children to undergo surgery and recover quickly. The first case to be witnessed in Asia of Moya Moya disease — a rare blood vessel (vascular) disorder in which […]

thaipr.net

8 ธ.ค. 65

Sirolimus Coated Balloon in BTK Treatment makes a bold presence at VEITH 2022 – Lights up NY Times Square, NASDAQ

VEITH 2022 witnessed a surge of supporting clinical data for Sirolimus Coated Balloon in the treatment of Below-the-Knee (BTK) disease. Concept Medical Inc. hosted a lunch symposium titled ‘Sirolimus Coated Balloon in PAD Treatment: Choice of The Future’ which explored the utility of Sirolimus Coated Balloon treatment in PAD. The session was chaired by Prof. Sahil […]

thaipr.net

7 ธ.ค. 65

FOUNDATION FOR ANGELMAN SYNDROME THERAPEUTICS (FAST) ANNOUNCES $5 MILLION GIFT TO ADVANCE CLINICAL TRIALS IN RARE NEURODEVELOPMENTAL DISORDERS

The Center at Rush University Will Be Directed By Dr. Elizabeth Berry-Kravis The Foundation for Angelman Syndrome Therapeutics (FAST) announced today a $5 million gift to establish the new clinical trial and translational research effort for rare neurodevelopmental disorders, a first-of-its-kind flagship center to be directed by Dr. Elizabeth Berry-Kravis. Named the Rush F.A.S.T. Center […]

thaipr.net

6 ธ.ค. 65

Menarini Group Presents Updated Results from Pivotal Phase 3 EMERALD Trial at the 2022 San Antonio Breast Cancer Symposium (SABCS) that Demonstrate Elacestrant’s PFS Increases with Duration of Prior CDK4/6i in ER+, HER2- in Metastatic Setting

Elacestrant demonstrated longer progression-free survival (PFS) vs SOC endocrine therapy with medians up to 8.6 months, positively associated with the duration of prior treatment with CDK4/6 inhibitors Elacestrant side effects were manageable and consistent with previously reported results  Results demonstrate that elacestrant may have the potential to become a new standard of care as a monotherapy endocrine sequencing […]

thaipr.net

6 ธ.ค. 65

Encore Medical Education announces publication of the Official Best of SABCS® News Highlights summarizing key trial results from the 2022 SABCS®

Best of SABCS® News Highlights coverage will provide daily expert video summaries along with original presentation slides of the most significant breast cancer trials for oncologists worldwide. Encore Medical Education, a US-based medical education company will launch the 2022 edition of the Best of SABCS® News Highlights program from the 2022 San Antonio Breast Cancer Symposium (SABCS®) starting December […]

thaipr.net

2 ธ.ค. 65
1 … 54 55 56 57 58 … 133

Copyright © 2025 Dataxet Limited (บริษัท ดาต้าเซ็ต จำกัด). All Rights Reserved.